Please login to the form below

Not currently logged in
Email:
Password:

Senior appointments at Glide Pharma

New chief financial officer and director of business development

Richard BungayGlide Pharma has appointed a chief financial officer and a director of business development as it prepares to scale up its commercial efforts.

Richard Bungay joins as chief financial officer from Verona, where he had served since September last year. Prior to this he was CEO of fellow UK biotech Chroma Therapeutics having previously been the company's chief financial officer.

His other previous include director of corporate communications and strategic planning at Celltech and finance director within the respiratory and inflammation therapy area at AstraZeneca.

New director of business development Tony Mills joins Glide from Q Chip where he was chief commercial officer.

Dr Mark Carnegie-Brown, Glide's CEO, commented: “Both are seasoned industry professionals, and attracting executives of their calibre is a testament to the progress Glide has made since completing a strategic fundraising last year for the scale-up of our device and formulation capabilities.”

9th July 2014

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics